Our news

Read through our press releases to follow Signifierʼs latest
news and updates

eXciteOSA Device and SmartPhone

Signifier Medical Technologies Announces Participation In Piper Sandler Healthcare Conference

Signifier Medical Technologies’ eXciteOSA®, the only FDA-authorized daytime therapy for primary snoring and mild obstructive sleep apnea, demonstrates real-world adherence to treatment of over 80%

Signifier Medical Technologies Announces $49MM Purchase of Existing Shares

Signifier Medical Technologies is granted HCPCS Codes for eXciteOSA

Signifier Medical Technologies Raises $35M in Series D Funding Round

New Era of Treatment for Sleep Apnea and Snoring with FDA Authorization of eXciteOSA® Device

IDEA Design Award 2020 for the World’s First, Daytime Treatment Device Tackling the Root Cause of Sleep-Disordered Breathing

Global Webinar on: “Precision Medicine and Non-Invasive Therapies for Mild Obstructive Sleep Apnea”

Webinar on Precision Medicine and Non-Invasive Therapies for Mild Obstructive Sleep Apnea

Global Webinar on: “Latest Advances in the Management of Sleep Disordered Breathing”

Webinar on Precision Medicine for Obstructive Sleep Apnea and Emerging Technologies

Webinar on eXciteOSA®: Novel Approach to Treatment of Snoring and Mild OSA

Webinar on Latest Advances in the Management of Sleep Disordered Breathing

Signifier Medical Technologies Wins iF Design Award 2020 for Design Excellence for eXciteOSA®